Reflux-Induced Oxidative Stress in Barrett's Esophagus: Response, Repair, and Epithelial-Mesenchymal-Transition
Completed · Not applicable
Conditions studied: Barrett's Esophagus, Gastroesophageal Reflux Disease
In brief
The purpose of this study is to elucidate mechanisms whereby oxidative stress induced by acute reflux esophagitis: 1) activates p38 to regulate proteins that control the G1/S cell cycle checkpoint, and 2) activates HIFs (hypoxia inducible factors) to cause autocrine VEGF (vascular endothelial growth factor) signaling that triggers the EMT (epithelial-mesenchymal-transition) program in Barrett's esophagus.
Key facts
- Study ID
- NCT02579460
- Run by
- Dallas VA Medical Center
- People needed
- 15
- Starts
- 2015-11-01
- Expected to finish
- 2017-11-01
- Last updated by the study team
- 2023-09-11
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- U.S. Veteran
- Barrett's Esophagus
You may not qualify if…
- Inability to provide informed consent
- Pregnancy or breastfeeding
- Esophageal varices
- Warfarin use
- Coagulopathy that precludes safe biopsy of the esophagus
- Comorbidity that precludes safe participation in the study
Where it is running
- Dallas VA Medical Center — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.